4 Issues To Watch As 21st Century Cures Act Advances

Law360, New York (May 21, 2015, 5:17 PM ET) -- Thursday's 51-0 vote to advance the 21st Century Cures Act to the full U.S. House of Representatives was an important milestone for a fast-evolving bill with big implications for drug and device makers, health insurers, doctors and hospitals. Here's a look at the latest changes and wild cards to watch.



New Funding Emerges



A 49-page amendment approved as part of Thursday's vote at the Energy & Commerce Committee addressed a key concern by earmarking $550 million over five years to help the U.S. Food and Drug...

To view the full article, register now.